Becomes an incorporated company with its three current partner organisations as shareholders
The board of directors at NWEH (left to right): Simon Merrywest, Director of Operations, Faculty of Biology, Medicine and Health, University of Manchester; Sam Bibby, Solicitor, University of Manchester; Oz Khan, Salford Royal Hospital Foundation Trust; Marie Kane, Chief Operating Officer, NWEH Limited; Anthony Hassall, Chief Operating Officer, Salford Clinical Commissioning Group; Martin Gibson, Chief Executive, NWEH Limited; Raj Jain, Exec Director of Corporate Strategy and Development, Salford Royal Foundation NHS Trust
North West EHealth (NWEH), the developer of innovative software for analysing health and care data, has become an incorporated company. The limited company’s shareholders are its three current partner organisations: Salford Royal Foundation Trust, Salford Clinical Commissioning Group and the University of Manchester.
NWEH was originally established in 2008 as a partnership between these three organisations to develop ground-breaking technology that uses routinely collected healthcare data to improve feasibility and recruitment for clinical trials and support the evaluation of healthcare improvements.
Based in Manchester and Salford Quays, NWEH now has a rapidly growing team of software engineers, database analysts, statisticians, researchers and support staff. Changing to a limited company structure is an important development that will allow NWEH to further grow while continuing its close collaboration with the NHS and academia.
'Our incorporation gives us greater flexibility to grow our capabilities and to reach a global audience,' said Martin Gibson, Chief Executive, NorthWest EHealth. 'We look forward to future collaborations and applying our ground-breaking technology, not only to clinical trials, but also to wearable technologies, new diagnostics and other emerging applications worldwide.'
'NWEH has been pivotal in the development of clinical trials, not least the Salford Lung Study, the largest ever real-world clinical trial,' said Professor Ian Greer, Vice-President and Dean, Faculty of Biology, Medicine and Health, The University of Manchester.
'Trials such as these are made possible by the technology and expertise of the NWEH team, which grew through collaboration with the partner organisations. NWEH is poised, with its incorporation, for much further success and we look forward to continuing a highly successful partnership.'